We are live on ! Find out more
CCA

Catalyst Capital Advisors Portfolio holdings

AUM $6.03B
1-Year Est. Return 24.5%
This Fund
S&P 500
This Quarter Est. Return
+2.67%
1 Year Est. Return
+24.5%
3 Year Est. Return
+62.66%
5 Year Est. Return
+62.45%
10 Year Est. Return
+241.55%
AUM
$3.03B
AUM Growth
+$167M
Cap. Flow
+$104M
Cap. Flow %
3.44%
Top 10 Hldgs %
66.49%
Holding
503
New
112
Increased
149
Reduced
96
Closed
91

Top Sells

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$18M
2
FTNT icon
Fortinet
FTNT
+$17.6M
3
PFE icon
Pfizer
PFE
+$17M
4
GWW icon
W.W. Grainger
GWW
+$16.9M
5
COP icon
ConocoPhillips
COP
+$15.6M

Sector Composition

Rank Sector Weight
1 Energy 6.74%
2 Technology 3.03%
3 Consumer Discretionary 2.11%
4 Healthcare 1.93%
5 Industrials 1.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SONM icon
351
DNA X Inc
SONM
$4.69M
0
SPFI icon
352
South Plains Financial
SPFI
$841M
$7K ﹤0.01%
+394
New +$6.96K
STNE icon
353
StoneCo
STNE
$2.62B
$7K ﹤0.01%
250
STOK icon
354
Stoke Therapeutics
STOK
$1.82B
$7K ﹤0.01%
+240
New +$6.45K
UBER icon
355
Uber
UBER
$134B
$7K ﹤0.01%
+150
New +$6.37K
WD icon
356
Walker & Dunlop
WD
$1.65B
$7K ﹤0.01%
125
WING icon
357
Wingstop
WING
$3.68B
$7K ﹤0.01%
+77
New +$6.27K
MORF
358
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$7K ﹤0.01%
+350
New +$6.62K
NGM
359
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$7K ﹤0.01%
+450
New +$6.59K
BCEL
360
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$7K ﹤0.01%
+350
New +$6.32K
TCRR
361
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$7K ﹤0.01%
459
MITO
362
DELISTED
Stealth BioTherapeutics Corp. ADS
MITO
$7K ﹤0.01%
568
CHNG
363
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$7K ﹤0.01%
+464
New +$6.87K
RTLR
364
DELISTED
Rattler Midstream LP Common Units
RTLR
$7K ﹤0.01%
+345
New +$6.61K
WORK
365
DELISTED
Slack Technologies, Inc.
WORK
$7K ﹤0.01%
+179
New +$6.59K
PRSP
366
DELISTED
Perspecta Inc. Common Stock
PRSP
$7K ﹤0.01%
281
+40
+17% +$899
PS
367
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
$7K ﹤0.01%
239
+59
+33% +$1.9K
PRVL
368
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
$7K ﹤0.01%
+500
New +$7.29K
APPF icon
369
AppFolio
APPF
$5.85B
$6K ﹤0.01%
+58
New +$5.48K
BJ icon
370
BJs Wholesale Club
BJ
$11.9B
$6K ﹤0.01%
243
+38
+19% +$1.01K
FSLY icon
371
Fastly Inc
FSLY
$3.17B
$6K ﹤0.01%
+300
New +$6.18K
FTDR icon
372
Frontdoor
FTDR
$5.02B
$6K ﹤0.01%
+149
New +$5.72K
FVRR icon
373
Fiverr
FVRR
$376M
$6K ﹤0.01%
+200
New +$6.12K
HLNE icon
374
Hamilton Lane
HLNE
$3.63B
$6K ﹤0.01%
+99
New +$4.97K
LEVI icon
375
Levi Strauss
LEVI
$9.44B
$6K ﹤0.01%
300

Similar funds

Catalyst Capital Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Catalyst Capital Advisors held 503 positions worth $3.03B, up 5.8% from $2.87B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Catalyst Capital Advisors deployed $104M of net new capital in Q2 2019, opening 112 new positions and adding to 149 existing holdings. Its largest new stake was Ametek: 162,000 shares worth $14.7M.

By sector, the portfolio is most concentrated in Energy at 6.7% of assets, down from 7.8% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Plains GP Holdings, an estimated $5.81M trimmed.

  • Catalyst Capital Advisors's largest Q2 2019 buy was Ametek: 162,000 shares worth $14.7M.
  • Catalyst Capital Advisors added most to iShares Core S&P Mid-Cap ETF in Q2 2019, an estimated $44M increase.
  • Catalyst Capital Advisors's biggest Q2 2019 reduction was Plains GP Holdings, cutting an estimated $5.81M.
  • Catalyst Capital Advisors fully exited Salesforce in Q2 2019, selling an estimated $18M.
  • Catalyst Capital Advisors's ten largest holdings make up 66% of its $3.03B portfolio in Q2 2019.
  • Catalyst Capital Advisors opened 112 new positions and closed 91 in Q2 2019.
  • Catalyst Capital Advisors's portfolio value rose 5.8% quarter-over-quarter to $3.03B.

Based on Catalyst Capital Advisors's 13F filing for Q2 2019, filed 8 Aug 2019.